Skip to content

Antiaging Quantum Living Inc.: 10-Q filed 2026-02-13

What Antiaging Quantum Living Inc. reported in its quarterly report filed 2026-02-13 (fiscal Q3 2026): 44 published measures, 119 facts as tagged in accession 0001493152-26-006710.

This filing

Form
10-Q (quarterly report)
Filed
2026-02-13
Fiscal period
fiscal Q3 2026
Accession
0001493152-26-006710 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Antiaging Quantum Living Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-12-311,810,259USD
At 2025-03-311,589,350USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-12-312,110,875USD
At 2025-03-312,719,367USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-12-31-300,616USD
At 2025-09-30-1,335,697USD
At 2025-06-30-1,271,326USD
At 2025-03-31-1,130,017USD
At 2024-12-31945,553USD
At 2024-09-30-841,700USD
At 2024-06-30-624,803USD
At 2024-03-31-413,170USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-12-31936,910USD
At 2025-03-31370,549USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-272,168USD92
2025-04-01 to 2025-12-31-467,138USD275
2025-07-01 to 2025-09-30-61,598USD92
2025-04-01 to 2025-06-30-133,372USD91
2024-10-01 to 2024-12-31-129,154USD92
2024-04-01 to 2024-12-31-540,808USD275
2024-07-01 to 2024-09-30-197,746USD92
2024-04-01 to 2024-06-30-213,908USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-04-01 to 2025-12-31254,539USD275
2024-04-01 to 2024-12-31-567,444USD275

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2025-10-01 to 2025-12-31340,292USD92
2025-04-01 to 2025-12-311,021,894USD275
2024-10-01 to 2024-12-31154,471USD92
2024-04-01 to 2024-12-31529,714USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-04-01 to 2025-12-31460,000USD275
2024-04-01 to 2024-12-31649,265USD275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-04-01 to 2025-12-31-162,417USD275
2024-04-01 to 2024-12-31-44,835USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-12-31-1,876,850USD
At 2025-03-31-1,409,712USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-10-01 to 2025-12-3131,716,441shares92
2025-04-01 to 2025-12-3130,570,900shares275
2024-10-01 to 2024-12-3129,995,000shares92
2024-04-01 to 2024-12-3129,995,000shares275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-10-01 to 2025-12-3131,716,441shares92
2025-04-01 to 2025-12-3130,570,900shares275
2024-10-01 to 2024-12-3129,995,000shares92
2024-04-01 to 2024-12-3129,995,000shares275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-0.0086USD/shares92
2025-04-01 to 2025-12-31-0.0153USD/shares275
2024-10-01 to 2024-12-31-0.0043USD/shares92
2024-04-01 to 2024-12-31-0.018USD/shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-0.0086USD/shares92
2025-04-01 to 2025-12-31-0.0153USD/shares275
2024-10-01 to 2024-12-31-0.0043USD/shares92
2024-04-01 to 2024-12-31-0.018USD/shares275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-10-01 to 2025-12-3155USD92
2025-04-01 to 2025-12-3116,500USD275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-12-31158,083USD
At 2025-03-31120,769USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-272,239USD92
2025-04-01 to 2025-12-31-461,664USD275
2024-10-01 to 2024-12-31-198,814USD92
2024-04-01 to 2024-12-31-610,515USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-12-311,268,336USD
At 2025-03-31810,515USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-12-311,381,862USD
At 2025-03-31677,826USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-12-316,435USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-03-3185,788USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-10-01 to 2025-12-31476,151USD92
2025-04-01 to 2025-12-311,224,781USD275
2024-10-01 to 2024-12-31348,125USD92
2024-04-01 to 2024-12-311,120,531USD275

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-12-31101,884USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-10-01 to 2025-12-31203,912USD92
2025-04-01 to 2025-12-31763,117USD275
2024-10-01 to 2024-12-31149,311USD92
2024-04-01 to 2024-12-31510,016USD275

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-10-01 to 2025-12-31136,380USD92
2025-04-01 to 2025-12-31258,777USD275
2024-10-01 to 2024-12-315,160USD92
2024-04-01 to 2024-12-3119,698USD275

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-12-311,527,204USD
At 2025-03-31243,530USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2025-12-3118,607USD
At 2025-03-316,170USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-12-31370,851USD
At 2025-03-31644,515USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-12-31379,368USD
At 2025-03-31412,790USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-12-31439,232USD
At 2025-03-31271,330USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-12-31281,149USD
At 2025-03-31150,561USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2025-12-3129,464USD
At 2025-03-318,475USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2025-12-31149,000USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-272,113USD92
2025-04-01 to 2025-12-31-450,638USD275
2024-10-01 to 2024-12-31-129,154USD92
2024-04-01 to 2024-12-31-540,808USD275

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-249,021USD92
2025-04-01 to 2025-12-31-454,701USD275
2024-10-01 to 2024-12-31-103,853USD92
2024-04-01 to 2024-12-31-532,383USD275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-10-01 to 2025-12-31400,923USD92
2025-04-01 to 2025-12-311,106,298USD275
2024-10-01 to 2024-12-31283,993USD92
2024-04-01 to 2024-12-31825,193USD275

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-04-01 to 2025-12-31122,643USD275
2024-04-01 to 2024-12-31108,180USD275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-04-01 to 2025-12-31123,690USD275
2024-04-01 to 2024-12-31108,180USD275

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-04-01 to 2025-12-311,047USD275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-10-01 to 2025-12-31126USD92
2025-04-01 to 2025-12-3111,026USD275
2024-10-01 to 2024-12-3169,660USD92
2024-04-01 to 2024-12-3169,707USD275

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2025-04-01 to 2025-12-3116,525USD275

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2025-04-01 to 2025-12-3154,000USD275
2024-04-01 to 2024-12-3112,000USD275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-04-01 to 2025-12-31-86,946USD275
2024-04-01 to 2024-12-3122,506USD275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-04-01 to 2025-12-31101,884USD275

Inspect the source

Entity
Antiaging Quantum Living Inc. / CIK 0001672571
Captured
2026-09-21T17:22:46.472Z
SEC response SHA-256
6cc8eafcc2590a1b39df620707e9ac7fa8fea950e5902e0c4f4e5e3303495ff6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001672571.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))